Correlation Between State Bank and GlaxoSmithKline PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both State Bank and GlaxoSmithKline PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining State Bank and GlaxoSmithKline PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between State Bank of and GlaxoSmithKline PLC, you can compare the effects of market volatilities on State Bank and GlaxoSmithKline PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in State Bank with a short position of GlaxoSmithKline PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of State Bank and GlaxoSmithKline PLC.

Diversification Opportunities for State Bank and GlaxoSmithKline PLC

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between State and GlaxoSmithKline is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding State Bank of and GlaxoSmithKline PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlaxoSmithKline PLC and State Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on State Bank of are associated (or correlated) with GlaxoSmithKline PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlaxoSmithKline PLC has no effect on the direction of State Bank i.e., State Bank and GlaxoSmithKline PLC go up and down completely randomly.

Pair Corralation between State Bank and GlaxoSmithKline PLC

Assuming the 90 days trading horizon State Bank of is expected to generate 1.34 times more return on investment than GlaxoSmithKline PLC. However, State Bank is 1.34 times more volatile than GlaxoSmithKline PLC. It trades about 0.07 of its potential returns per unit of risk. GlaxoSmithKline PLC is currently generating about 0.0 per unit of risk. If you would invest  6,738  in State Bank of on August 31, 2024 and sell it today you would earn a total of  3,242  from holding State Bank of or generate 48.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

State Bank of  vs.  GlaxoSmithKline PLC

 Performance 
       Timeline  
State Bank 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in State Bank of are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, State Bank is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
GlaxoSmithKline PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

State Bank and GlaxoSmithKline PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with State Bank and GlaxoSmithKline PLC

The main advantage of trading using opposite State Bank and GlaxoSmithKline PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if State Bank position performs unexpectedly, GlaxoSmithKline PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlaxoSmithKline PLC will offset losses from the drop in GlaxoSmithKline PLC's long position.
The idea behind State Bank of and GlaxoSmithKline PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Transaction History
View history of all your transactions and understand their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world